ACE inhibitors (ACE-Is) and angiotensin II receptor blockers (ARBs), two common therapies for hypertension, increase ACE2 levels in some tissues such as the myocardium, contributing to protection against cardiovascular disease (CVD) [32]. This evidence concerns the gene ACE2 and hypertensive disorder.